Atea Pharmaceuticals, Inc. · NASDAQ:AVIR
Radoff Bradley Louis reported a 3.60% stake in Atea Pharmaceuticals, Inc. (Schedule 13D/A)
Event Mar 20, 2025 · Filed Mar 21, 2025
Radoff Bradley Louis reported a 3.60% stake in Atea Pharmaceuticals, Inc., 3,105,100 shares, with active intent on Mar 20, 2025. Filed Mar 21, 2025 (Schedule 13D/A).
- Stake
- 3.60%
- Shares
- 3,105,100
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Radoff Family Foundation | 0.20% | 175,000 |
| Radoff Bradley Louis | 3.60% | 3,105,100 |
| JEC II Associates, LLC | 1.50% | 1,300,000 |
| The MOS Trust | 0.10% | 100,000 |
| MOS PTC, LLC | 0.10% | 100,000 |
| Torok Michael | 1.80% | 1,500,000 |
| Berman Howard H. | 0% | 0 |
| Nerium Partners LP | 0.10% | 54,000 |
| Nerium Capital LLC | 0.10% | 54,000 |
| Flynn James P. | 0.10% | 54,000 |
Source
Related
- Atea Pharmaceuticals, Inc.
- Radoff Bradley Louis
- Atea Pharmaceuticals, Inc. shareholders
- Schedule 13D/A · Radoff Bradley Louis · Apr 17, 2025
- Schedule 13D · Radoff Bradley Louis · Mar 4, 2025
- Schedule 13G · Tang Capital Management LLC · Oct 6, 2026
- Form 4 · Lucidi Bruno · Jun 23, 2026
- Form 4 · Berger Franklin M · Jun 23, 2026
- Form 4 · Duncan Barbara Gayle · Jun 23, 2026
- Form 4 · Adams Jerome M. · Jun 23, 2026